[ASND] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
27-Apr-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -9.48%
YoY- -49.33%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 35,998 47,393 6,160 1,022 1,436 3,211 18 254.54%
PBT -109,151 -121,862 -81,366 -134,442 -95,038 -58,969 -22,876 29.71%
Tax 229 -429 -47 -68 -106 -65 -99 -
NP -109,380 -121,433 -81,319 -134,374 -94,932 -58,904 -22,777 29.85%
Tax Rate - - - - - - - -
Total Cost 145,378 168,826 87,479 135,396 96,368 62,115 22,795 36.14%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -303.85 -256.23 -1,320.11 -13,148.14 -6,610.86 -1,834.44 -126,538.89 -63.37%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -1.91 -2.16 -1.46 -2.50 -1.97 -1.25 -0.55 23.03%
EPS Diluted -1.91 -2.16 -1.46 -2.50 -1.97 -1.25 -0.55 23.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.